All Stories

  1. Bromelain in Obesity Therapy: A Review of Anti-Inflammatory and Metabolic Mechanisms
  2. Anti-Oxidant and Anti-Cancer Properties of Flaxseed
  3. The Influence of Body Composition, Lifestyle, and Dietary Components on Adiponectin and Resistin Levels and AR Index in Obese Individuals
  4. Placental Cannabinoid Receptor Expression in Preterm Birth
  5. Anti-Cancer and Anti-Inflammatory Properties of Black Garlic
  6. Health-Promoting Properties: Anti-Inflammatory and Anticancer Properties of Sambucus nigra L. Flowers and Fruits
  7. Vitamin D as a Nutri-Epigenetic Factor in Autoimmunity—A Review of Current Research and Reports on Vitamin D Deficiency in Autoimmune Diseases
  8. IL-17A, IL-17E and IL-17F as Potential Biomarkers for the Intensity of Low-Grade Inflammation and the Risk of Cardiovascular Diseases in Obese People
  9. MicroRNA gene methylation landscape in pediatric B-cell precursor acute lymphoblastic leukemia
  10. LncCDH5-3:3 Regulates Apoptosis, Proliferation, and Aggressiveness in Human Lung Cancer Cells
  11. Correlation between rheumatoid arthritis and periodontitis
  12. Evaluation of Selected Parameters of the Specific Immune Response against Pseudomonas aeruginosa Strains
  13. Potential Immunomodulatory Effects from Consumption of Nutrients in Whole Foods and Supplements on the Frequency and Course of Infection: Preliminary Results
  14. Dietary Intake of Endocrine Disrupting Substances Presents in Environment and Their Impact on Thyroid Function
  15. Effect of interleukin-6, -17, -21, -22, and -23 and STAT3 on signal transduction pathways and their inhibition in autoimmune arthritis
  16. Coincidence of selective immunoglobulin A deficiency in juvenile idiopathic arthritis – a series of three cases
  17. An association of iNKT+/CD3+/CD161+ lymphocytes in ovarian cancer tissue with CA125 serum concentration
  18. MEASUREMENT OF LYCOPENE EFFECTIVENESS ON LUNG AND KIDNEY CANCER CELLS BY QUANTITATIVE 1H MAGNETIC RESONANCE IMAGING IN VITRO
  19. An association of circulating Tregs and Th17 cells producing IL-21 and IL-22 with the ROMA in ovarian cancer patients
  20. Salivary IL-17A, IL-17F, and TNF-α Are Associated with Disease Advancement in Patients with Oral and Oropharyngeal Cancer
  21. MRI as a potential tool for monitoring of therapeutic monoclonal antibody distribution in cancer patients
  22. Contrast-enhanced Magnetic Resonance Imaging of lung cell cultures
  23. Glycosylation of immune system proteins and its role in autoimmune diseases and cancer
  24. Lycopene activity on lung and kidney cancer cells by T2 relaxation time 1H Magnetic Resonance Imaging in vitro
  25. The Influence of Lycopene, [6]-Gingerol, and Silymarin on the Apoptosis on U-118MG Glioblastoma Cells In Vitro Model
  26. Cytokine Levels in the In Vitro Response of T Cells to Planktonic and Biofilm Corynebacterium amycolatum
  27. 306 Treg cells and TH17 cells producing IL-21 and IL-22 in a ROMA relationship of patients affected by ovarian tumours
  28. Expression of heat shock protein 70 in the tissue of patients with laryngeal squamous cell carcinoma
  29. Fibrodysplasia Ossificans Progressiva – a presentation of cases and literature review
  30. How genetic predispositions may have impact on injury and success in sport
  31. Optimization of detection of circulating tumor cells by flow cytometry and qRT-PCR
  32. Scientific reports concerning the impact of interleukin 4, interleukin 10 and transforming growth factor  on cancer cells
  33. Assessment of Postvaccine Immunity against Streptococcus pneumoniae in Patients with Asplenia, including an Analysis of Its Impact on Bacterial Flora of the Upper Respiratory Tract and Incidence of Infections
  34. The role of pro-inflammatory cytokines in the pathogenesis and progression of neoplasms
  35. Females and Autism
  36. Autoimmunity in Reproductive Health and Pregnancy
  37. Cytokines in Preterm Delivery: Proposal of a New Diagnostic Algorithm
  38. Selected miRNA levels are associated with IKZF1 microdeletions in pediatric acute lymphoblastic leukemia
  39. Assessment of Th17 lymphocytes and cytokine IL-17A in epithelial ovarian tumors
  40. Trophic Activity and Phenotype of Adipose Tissue-Derived Mesenchymal Stem Cells as a Background of Their Regenerative Potential
  41. 19F MRI As a tool for imaging drug delivery to tissue and individual cells
  42. An overview of the preclinical and clinical studies of the effects of tumor treating fields on malignant glioma cells
  43. Chemiluminescence-driven Dye Excitation for Dark Photodynamic Therapy
  44. Influence of antiphospholipid antibody positivity on glomerular filtration rate markers in a group of systemic sclerosis patients – a 24-month observation
  45. Investigation of pharmaceuticals by nuclear magnetic resonance imaging and spectroscopy
  46. Laser flow cytometry as a tool for the advancement of clinical medicine
  47. MGMT promoter methylation as a potential prognostic marker for acute leukemia
  48. Monocytic myeloid-derived suppressor cells as a potent suppressor of tumor immunity in non-small cell lung cancer
  49. Presence of organ‑specific antibodies in patients with systemic sclerosis
  50. Increased percentage of Th17 cells in peritoneal fluid is associated with severity of endometriosis
  51. Endocannabinoid system as a regulator of tumor cell malignancy – biological pathways and clinical significance
  52. Indoleamine 2,3-dioxygenase mediates inhibition of virus-specific CD8+ T cell proliferation by human mesenchymal stromal cells
  53. Regulatory T lymphocytes and transforming growth factor beta in epithelial ovarian tumors-prognostic significance
  54. The Role of IL-17 and Th17 Lymphocytes in Autoimmune Diseases
  55. Prevalence of selected organ-specific autoantibodies in rheumatoid arthritis and primary Sjögren’s syndrome patients
  56. Umbilical cord blood as a source of nerve and stem cells
  57. T regulatory lymphocytes in patients with endometriosis
  58. A Modified Method of Insulin Producing Cells’ Generation from Bone Marrow-Derived Mesenchymal Stem Cells
  59. Percentages of NKT cells in the tissues of patients with non-small cell lung cancer who underwent surgical treatment
  60. Surgery decreases number of cells secreting cytotoxic mediators and increases secretion of interleukin 10 in patients with lung cancer
  61. Impact of cladribine therapy on changes in circulating dendritic cell subsets, T cells and B cells in patients with multiple sclerosis
  62. The expression of B7-H1 and B7-H4 co-stimulatory molecules on myeloid and plasmacytoid dendritic cells in pre-eclampsia and normal pregnancy
  63. NKT cells: their development, mechanisms and effects of action
  64. The Expressions of Co‐Stimulatory Molecules are Altered on Putative Antigen‐Presenting Cells in Cord Blood
  65. Dendritic cells: active and passive players in therapy of human diseases
  66. Apoptosis Signaling Is Altered in CD4+CD25+FoxP3+ T Regulatory Lymphocytes in Pre-Eclampsia
  67. Dendritic cell subsets in neoplastic tissue and peripheral blood of laryngeal cancer patients: relation with grade and stage of the disease
  68. The predominance of Th17 lymphocytes and decreased number and function of Treg cells in preeclampsia
  69. BADANIA KLINICZNE I DOŚWIADCZALNE W CHOROBACH SERCA, PŁUC I NACZYŃ Death instead of activation – a study of lymphocyte apoptosis in the tumor draining lymph nodes and in the tumor tissue
  70. Anaerobic bacteria colonizing the lower airways in lung cancer patients
  71. Evaluation of monocyte-derived dendritic cells, T regulatory and Th17 cells in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors
  72. Identification of dendritic cells in the blood and synovial fluid of children with Juvenile Idiopathic Arthritis
  73. Definition of a Target for Immunotherapy and Results of the First Peptide Vaccination Study in Chronic Lymphocytic Leukemia
  74. Immunomodulatory effects of vitamin D on monocyte-derived dendritic cells in multiple sclerosis
  75. Immunomodulatory Effects of IFN-β and Lovastatin on Immunophenotype of Monocyte-Derived Dendritic Cells in Multiple Sclerosis
  76. SCID mice model in vivo evaluation of autologous and allogeneic dendritic cells activity on B-cell chronic lymphocytic leukemia.
  77. Lipoprotein (a) in patients with psoriasis: associations with lipid profiles and disease severity
  78. Changes in circulating dendritic cells and B-cells in patients with multiple sclerosis relapse during corticosteroid therapy
  79. The effect of Propionibacterium acnes on maturation of dendritic cells derived from acne patients' peripherial blood mononuclear cells.
  80. Dendritic cells based immunotherapy of patient with chondrosarcoma--case report.
  81. Vaccination of B-CLL patients with autologous dendritic cells can change the frequency of leukemia antigen-specific CD8+ T cells as well as CD4+CD25+FoxP3+ regulatory T cells toward an antileukemia response
  82. Analysis of blood dendritic cells and lymphocytes in patients with autoimmune polyglandular syndromes (APS) and isolated autoimmune endocrine diseases — a pilot study
  83. The role of cytokines in juvenile idiopathic arthritis
  84. Activated T Lymphocytes in Pre‐Eclampsia
  85. Large‐scale generation of autologous dendritic cells for immunotherapy in patients with acute myeloid leukemia
  86. Plasma Interleukin-18 and Dendritic Cells in Males with Psoriasis Vulgaris
  87. Serum pancreatic lipase [EC 3.1.1.3] activity, serum lipid profile and peripheral blood dendritic cell populations in normolipidemic males with psoriasis
  88. Dendritic cells heterogeneity and its role in cancer immunity
  89. Allogeneic dendritic cells pulsed with tumor lysates or apoptotic bodies as immunotherapy for patients with early-stage B-cell chronic lymphocytic leukemia
  90. CD1c+ immature myeloid dendritic cells are predominant in cord blood of healthy neonates
  91. Blood myeloid and lymphoid dendritic cells are stable during the menstrual cycle but deficient during mid-gestation
  92. Myeloid and lymphoid dendritic cells in normal pregnancy and pre-eclampsia
  93. Immunotherapy with irradiated autologous leukemic cells in patients with B-CLL in early stages